https://www.aacr.org/meeting/aacr-io-2026/
Make plans to join us again in Los Angeles for AACR IO 2026—encompassing the very best of basic, translational, and clinical research in immunology, inflammation, and immunotherapies for cancer, including immuno-oncology (IO) drugs, inflammatory modulators, vaccines, and cellular therapies. The inaugural AACR IO 2025 program attracted over 600 basic scientists, translational researchers, clinical investigators, regulators, industry, investors, and lay press. The comprehensive and unique format included a mix of keynote lectures, major symposia, spotlight sessions, educational sessions, special sessions, and poster sessions with exhibits – sign-up for more information above for AACR IO 2026.